With my first degree in Chinese Medicine, I was a registered hospital pharmacist in Shanghai, but it was during my postgraduate training in the School of Pharmacy in Sydney, that I developed my strong interest in analytical sciences. During my PhD in Australia, I was one of the pioneers in the research and technology developments underpinning the ‘proteome’ concept which was the start of my development into an international expert in proteomics. After Sydney, I worked in two world leading proteomic groups (at Geneva Hospital and Imperial College London) to further my proteomics expertise and academic understanding and later became a leading scientist in developing a state-of-the-art proteomic platform in one of the top five bioscience companies in the UK.

Since joining NIBSC in 2003, my work has been directed towards the analysis of biological medicines. I have established a proteomics and mass spectrometry facility from ground zero to fulfill the aims and work programmes of the Institute. I use my in-depth knowledge and broad experience in analytical sciences to apply the use of appropriate technologies, to produce scientific advice and results for complex vaccines and biotherapeutics.

My career in academia, industry and institute has given me a deep understanding of biological medicines and the requirements for a multi-disciplinary approach to their characterisation and analysis. My research interests focus on the regulatory sciences of complex vaccine and biotherapeutics including identification, characterisation, quantitation and quality control attributes.